An interactive online LGBT cultural competency training program for oncologists may be acceptable, feasible, and improve LGBT-related knowledge and clinical practices, according to preliminary results of a pilot study of ...
Nov 2, 2018
0
0
(HealthDay)—At least 15 men who worked near Ground Zero after the 9/11 attacks have been diagnosed with breast cancer, a New York City law firm claims.
Sep 13, 2018
0
4
The previous decade has seen dramatic advances in the treatment of non-small cell lung cancer, as genes driving subtypes of the disease including EGFR, ALK, ROS1 and BRAF are paired with drugs that silence their action. However, ...
Aug 9, 2018
0
7
A study in today's issue of JAMA Oncology reports that New York City firefighters exposed to the 9/11 World Trade Center disaster site face an increased risk for developing myeloma precursor disease (MGUS), which can lead ...
Apr 26, 2018
0
495
Your immune system never sleeps. Every moment of the day, immune cells monitor your body for disease, calling for backup when they detect a threat. It's a system that works elegantly—most of the time. It's not foolproof; ...
Apr 5, 2018
0
34
Receptivity to advertising for e-cigarettes, cigarettes and cigars were confirmed to be associated with those who would try the respective tobacco product within one year. However, receptivity to e-cigarette advertising also ...
Mar 26, 2018
0
3
Childhood cancer is highly curable and, through collaboration, effective treatment is possible even in a crisis, according to an analysis from St. Jude Children's Research Hospital and the Children's Cancer Center of Lebanon ...
Feb 28, 2018
0
1
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) is one of four cancer centers involved in testing a new "nanomedicine" ...
Jan 9, 2018
0
299
(HealthDay)—Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found.
Dec 6, 2017
0
1
Several patients with recurring glioblastoma, a deadly brain cancer, survived for more than a year in a clinical trial believed to be the first to use comprehensive DNA and RNA sequencing of a patient's tumor to inform treatment ...
Oct 26, 2017
0
5
